Stacey L. Clardy MD, PhD
Associate Professor, Department of Neurology, University of Utah School of Medicine; Staff Neurologist, George E. Wahlen Department of Veteran Affairs, Salt Lake City, UtahStacey Clardy is tenured associate professor at the University of Utah with an appointment at the Salt LAke City VHA. She is the principal investigator (PI) of an NIH U01 grant (via the NeuroNEXT Clinical Trials Network) to fund the ExTINGUISH Trial—the first prospective, international, and randomized clinical trial for NMDA receptor encephalitis, at 20 US sites and 2 European sites, with enrollment currently ongoing. She established the autoimmune neurology clinic at the University of Utah—one of the few clinics in the United States focused on serving this group of patients. Dr. Clardy is also the director of the Autoimmune Neurology Fellowship program, and the editor of the Neurology Podcast for the journal Neurology and the Neurology Minute for the American Academy of Neurology.
Disclosures
Dr. Clardy reports the following:- Clinical Trials, Industry-sponsored: Site investigator for the Alexion clinical trial for Eculizumab in Relapsing NMO patients, now in long-term follow-up, and the UCB clinical trial for relapsing MOGAD patients (cosMOG), currently actively enrolling.
- Research support from NIH/NINDS (U01, The ExTINGUISH Trial, I am the PI), the Siegel Rare Neuroimmune Association, the Immune Deficiency Foundation, Horizon/Amgen, Alexion/AstraZeneca, the Barbara Gural Steinmetz Foundation, Sumaira Foundation for NMO.
- Consulting/Ad Board: Alexion/AstraZeneca, Horizon/Amgen.
- Medical Advisory Board of the Sumaira Foundation for NMO (unpaid)
- Section Editor, Neurology Podcast and Neurology Minute. Editorial Board, Neurology: Neuroimmunology and Neuroinflammation.